Prevention and treatment of erythroblastosis fetalis.
D000017:ABO Blood-Group System; D000906:Antibodies / Q000008:administration & dosage; D000917:Antibody Formation; D004899:Erythroblastosis, Fetal / Q000517:prevention & control* / Q000628:therapy*; D005260:Female; D005331:Fetomaternal Transfusion; D006648:Histocompatibility; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007231:Infant, Newborn; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins / Q000008:administration & dosage*
D000017:ABO Blood-Group System; D000906:Antibodies; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins